期刊文献+

Ⅱ型胶原口腔喷雾剂对小鼠胶原性关节炎的治疗作用(英文)

Effects of chicken typeⅡcollagen oral spraying on collagen-induced arthritis in mice
下载PDF
导出
摘要 目的 观察鸡Ⅱ型胶原 (CⅡ )口腔喷雾剂对小鼠胶原性关节炎 (CIA)是否具有治疗作用及相关的机理。方法 建立小鼠CIA模型 ,观测关节积分变化。MTT法检测脾淋巴细胞增殖反应 ,腹腔巨噬细胞产生白介素 1(IL 1)及脾淋巴细胞产生白介素 2 (IL 2 )的活性。结果 CⅡ口腔喷雾剂 (5 ,10 ,2 0μg·kg- 1·d- 1× 10d ,免疫后d 2 5~d 35 )均能降低CIA小鼠关节积分 ,且作用与igCⅡ (10 μg·kg- 1·d- 1× 10d)及泼尼松龙 (2mg·kg- 1·d- 1× 10d)相当。口腔喷雾CⅡ (10 ,2 0 μg·kg- 1·d- 1× 10d)能抑制CIA小鼠刀豆蛋白A诱导的脾淋巴细胞增殖反应和IL 1、IL 2的产生活性。结论 CⅡ口腔喷雾剂能抑制CIA小鼠多发性关节炎 ,提示其对CIA小鼠有治疗作用。其机理可能与改善CIA小鼠异常的免疫功能有关。 AIM To examine whether chicken typeⅡcollagen (CⅡ) oral spraying has the therapeutic effect on the collagen-induced arthritis (CIA) in mice and investigate its related immunological mechanisms. METHODS CIA mouse model was established. The effect of treatment with CⅡspraying in mice was measured by paw-swelling score. Splenocytes proliferation, activity of interleukin-1 (IL-1) produced by peritoneal macrophages(PM) and interleukin-2 (IL-2) by splenocytes were assayed by MTT method. RESULTS CⅡ oral spraying(5, 10, 20 μg·kg -1 ·d -1 ×10 d, d 25-35 after immunization) decreased the mean of arthritis scores in CIA mice. The effect of CⅡ spraying was comparable with that of ig CⅡ and prednisone. Meanwhile, CⅡ oral spraying (10, 20 μg·kg -1 ·d -1 ×10 d) suppressed the ConA-induced splenocyte proliferation and the activity of IL-1 and IL-2 in CIA mice. CONCLUSION CⅡoral spraying suppresses the polyarthritis of CIA mice, which suggests that CⅡoral spraying have therapeutic effect on CIA mice. Its mechanism maybe related to the modification of the abnormal immunological function of CIA mice.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2002年第6期449-453,共5页 Chinese Journal of Pharmacology and Toxicology
关键词 Ⅱ型胶原 口腔喷雾剂 胶原性关节炎 治疗 collagen arthritis collagen diseases lymphocytes cell proliferation interleukin-1 interleukin-2
  • 相关文献

参考文献8

  • 1[1]Xiao BG, Link H. Mucosal tolerance: a two-edged sword to prevent and treat autoimmune disease[J]. Clin Immunol Immunopathol, 1997, 85(2):119-128.
  • 2[2]Garside P, Mowat AM, Khoruts A. Oral tolerance in disease[J]. Gut, 1999, 44(1):137-142.
  • 3[3]Myers LK, Rosloniec EF, Cremer MA, Kang AH. Collagen-induced arthritis:an animal model of autoimmunity[J]. Life Sci, 1997, 61(19):1861-1878.
  • 4[4]Oliver SJ, Banquerigo ML, Brahn E. Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, Taxol[J]. Cell Immunol, 1994, 157(1):291-299.
  • 5[5]Wei W, Shen YX, Xu SY. Experimental methodology of immunodepressant and immunoenhancer[A]. In:Xu SY, Bian RL, Chen X, eds. Methodology of Pharmacological Experiments(药理实验方法学)[M]. 3rd ed. Beijing:People′s Medical Publishing House, 2002. 1421-1440.
  • 6[6]MacDonald TT. T cell immunity to oral allergens[J]. Curr Opin Immunol, 1998, 10(6):620-627.
  • 7[7]Myers LK, Seyer JM, Stuart JM, Kang AH. Suppression of murine collagen-induced arthritis by nasal administration of collagen[J]. Immunology, 1997, 90(2):161-164.
  • 8[8]Bendele A,McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical date[J]. Arthritis Rheum, 1999, 42(3):498-506.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部